EXPANDING THE USE OF REAL-WORLD DATA TO ANSWER CLINICAL PHARMACOLOGY QUESTIONS: DEVELOPMENT OF A USER-FRIENDLY DASHBOARD TO ASSESS PREVALENCE OF ORGAN IMPAIRMENT IN PATIENTS IN THE REAL-WORLD SETTING

被引:0
|
作者
Vora, B. [1 ]
Velasquez, E. [1 ]
Zhang, R. [1 ]
Igras, K. [2 ]
James, S. [1 ]
机构
[1] Genentech Inc, San Francisco, CA USA
[2] 7N Spzoo, Warsaw, Poland
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PII-033
引用
收藏
页码:S58 / S58
页数:1
相关论文
共 50 条
  • [1] Expanding the use of real-world data through the development of user-friendly tools to support drug development: Example of an organ impairment dashboard
    Vora, Bianca
    Velasquez, Erick
    Zhang, Rong
    Igras, Krystian
    James, Spencer L.
    Chanu, Pascal
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2024, 12 (04):
  • [2] Clinical Pharmacology Applications of Real-World Data and Real-World Evidence in Drug Development and Approval-An Industry Perspective
    Zhu, Rui
    Vora, Bianca
    Menon, Sujatha
    Younis, Islam
    Dwivedi, Gaurav
    Meng, Zhaoling
    Datta-Mannan, Amita
    Manchandani, Pooja
    Nayak, Satyaprakash K.
    Tammara, Brinda
    Garhyan, Parag
    Iqbal, Shahed
    Dagenais, Simon
    Chanu, Pascal
    Mukherjee, Arnab
    Ghobadi, Cyrus
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (04) : 751 - 767
  • [3] The Use of Real-world Data to Generate Real-world Evidence to Accelerate Neonatal Drug Development
    Jackson, Shawn S.
    Cravero, Joseph P.
    Sun, Lena
    Davis, Jonathan M.
    JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 2025, 37 (01) : 110 - 113
  • [4] Prevalence of positive bronchodilator response in a real-world clinical setting
    Tan, Geak Poh
    Chai, Gin Tsen
    Qi, Danqing
    Abisheganaden, John Arputhan
    RESPIROLOGY, 2023, 28 : 147 - 148
  • [5] Real-World Data and Clinical Pharmacology: A Regulatory Science Perspective
    Liu, Qi
    Ramamoorthy, Anuradha
    Huang, Shiew-Mei
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (01) : 67 - 71
  • [6] The use of real-world data to address questions of patient safety
    Yates, Mark
    Bechman, Katie
    Galloway, James
    RHEUMATOLOGY, 2020, 59 (01) : 26 - 30
  • [7] Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective
    Chen, Jie
    Gruber, Susan
    Lee, Hana
    Chu, Haitao
    Lee, Shiowjen
    Tian, Haijun
    Wang, Yan
    He, Weili
    Jemielita, Thomas
    Song, Yang
    Tamura, Roy
    Tian, Lu
    Zhao, Yihua
    Chen, Yong
    van Der Laan, Mark
    Nie, Lei
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025, 117 (04) : 946 - 960
  • [8] The use of real-world data for clinical investigation of effectiveness in drug development
    Wang, Peijin
    Chow, Shein-Chung
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2024, 34 (06) : 818 - 841
  • [9] The use of real-world data in cancer drug development
    Skovlund, E.
    Leufkens, H. G. M.
    Smyth, J. F.
    EUROPEAN JOURNAL OF CANCER, 2018, 101 : 69 - 76
  • [10] High albuminuria in CKD: prevalence and characteristics in a real-world clinical setting
    Svensson, Maria K.
    Bodegard, Johan
    Thuresson, Marcus
    Ambery, Philip
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39